|
P-190 NALIRIFOX (iposomal irinotecan + 5-fluorouracil/feucovorin + oxaliplatin) versus FOLFOX [5-fluorouracil/leucovorin + oxaliplatin] as first-line treatment of metastatic pancreatic ductal adenocarcinoma (mPDAC): Real-world comparative overall survival |
|
|
|
Titel: |
P-190 NALIRIFOX (iposomal irinotecan + 5-fluorouracil/feucovorin + oxaliplatin) versus FOLFOX [5-fluorouracil/leucovorin + oxaliplatin] as first-line treatment of metastatic pancreatic ductal adenocarcinoma (mPDAC): Real-world comparative overall survival |
Auteur: |
O'Reilly, E. Li, J. DerSarkissian, M. Chang, R. Cheng, M. Yu, L. Rane, D. Zhang, l. Xiao, Z. Benzaghou, F. Duh, M. Chen, H. |
Verschenen in: |
Annals of oncology |
Paginering: |
Jaargang 34 () nr. S1 pagina's S83 |
Jaar: |
2023 |
Inhoud: |
|
Uitgever: |
Published by Elsevier B.V. |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|